ISDA

Deposition Date 2005-11-09

Release Date 2006-01-11

Last Version Date 2023-12-13

Entry Detail

PDB ID:

2C6E

Keywords:

TRANSFERASE/INHIBITOR

Title:

Aurora A kinase activated mutant (T287D) in complex with a 5- aminopyrimidinyl quinazoline inhibitor

Biological Source:

Source Organism:

HOMO SAPIENS (Taxon ID: 9606)

Host Organism:

ESCHERICHIA COLI

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.10 Å

R-Value Free:

0.27

R-Value Work:

0.20

Space Group:

P 1 21 1

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:SERINE/THREONINE-PROTEIN KINASE 6
Gene (Uniprot):AURKA
Mutations:YES
Chain IDs:A, B
Chain Length:283
Number of Molecules:2
Biological Source:HOMO SAPIENS

UniProt ID:O14965 Pfam ID:PF00069 EC:2.7.11.1

Ligand Molecules

HPM

Primary Citation

Sar and Inhibitor Complex Structure Determination of a Novel Class of Potent and Specific Aurora Kinase Inhibitors.

Heron, N.M, Anderson, M, Blowers, D.P, Breed, J, Eden, J.M, Green, S, Hill, G.B, Johnson, T, Jung, F.H, Mcmiken, H.H.J, Mortlock, A.A, Pannifer, A.D, Pauptit, R.A, Pink, J, Roberts, N.J, Rowsell, S.Show

Bioorg.Med.Chem.Lett. 16 1320 ? (2006)

PMID: 16337122 DOI: 10.1016/J.BMCL.2005.11.053

Abstact

A novel series of 5-aminopyrimidinyl quinazolines has been developed from anilino-quinazoline 1, which was identified in a high throughput screen for Aurora A. Introduction of the pyrimidine ring and optimisation of the substituents both on this ring and at the C7 position of the quinazoline led to the discovery of compounds that are highly specific Aurora kinase inhibitors. Co-crystallisation of one of these inhibitors with a fragment of Aurora A shows the importance of the benzamido group in achieving selectivity.

Legend

Protein

Chemical

Disease

Primary Citation of related structures